At least 12 biotechs and pharmas are slated to report earnings this week. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), which markets H.P. Acthar Gel repository corticotropin injection for multiple sclerosis and infantile spasms, is expected to report a 2X increase in 4Q12 EPS on an 89% jump in revenues to $142.6 million. 4Q12 EPS for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is anticipated to be up 3.5X on a 6% increase